Advanced Search
XU Jiaxuan, ZUO Yifan, SUN Jingjing, CHEN Bing. Prognostic Analysis of Socioeconomic Factors in Multiple Myeloma Patients and Construction of A Myeloma-specific Survival Prediction Model[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 370-377. DOI: 10.3971/j.issn.1000-8578.2023.22.1075
Citation: XU Jiaxuan, ZUO Yifan, SUN Jingjing, CHEN Bing. Prognostic Analysis of Socioeconomic Factors in Multiple Myeloma Patients and Construction of A Myeloma-specific Survival Prediction Model[J]. Cancer Research on Prevention and Treatment, 2023, 50(4): 370-377. DOI: 10.3971/j.issn.1000-8578.2023.22.1075

Prognostic Analysis of Socioeconomic Factors in Multiple Myeloma Patients and Construction of A Myeloma-specific Survival Prediction Model

Funding: 

Jiangsu Provincial Medical Innovation Team CXTDA2017046

More Information
  • Corresponding author:

    CHEN Bing, E-mail: chenbing_nju@126.com

  • Received Date: September 14, 2022
  • Revised Date: December 29, 2022
  • Available Online: January 12, 2024
  • Objective 

    To investigate the effects of socioeconomic factors on the prognosis of multiple myeloma (MM) patients and construct a prediction model for evaluating myeloma-specific survival (MSS) rates.

    Methods 

    A total of 32625 patients diagnosed with MM between January 2007 and December 2016 were included through the SEER database. Cox regression model was used to analyze the predictive indicators of MSS. The results of the multivariate subgroup analysis were presented as forest plots. The significant factors identified in the multivariate Cox analysis were used to construct a nomogram. The predictive performance of the nomogram was assessed using the AUC and calibration plots. A nomogram score-based risk stratification system was constructed using a restricted cubic spline.

    Results 

    Patients were divided into five groups according to their socioeconomic status (SES). Groups with higher SES had relatively higher proportions of those part of the White, insured, married, and urban populations. Age, gender, race, marital status, insurance status, and SES were independent prognostic factors of MSS (all P < 0.001). The linear trend of increased MSS risk with decreasing SES was most pronounced among the White, married, insured, and urban patients (all P < 0.001). The nomogram exhibited good discrimination and accuracy in both training and validation sets, showing AUC values of 0.701, 0.709, and 0.722 for predicting 3-, 5-, and 8-year MSS, respectively. A risk stratification model was established based on the nomogram total points and the HR, which then divided patients into three different risk levels with substantial survival disparities (all P < 0.001).

    Conclusion 

    Socioeconomic factors, such as marital status, insurance status, and SES, have a significant impact on the survival outcomes of MM patients. The nomogram and the risk stratification model based on these factors can accurately and reliably predict MSS.

  • Competing interests: The authors declare that they have no competing interests.

  • [1]
    Kumar SK, Rajkumar V, Kyle RA, et al. Multiple myeloma[J]. Nat Rev Dis Primers, 2017, 3: 17046. doi: 10.1038/nrdp.2017.46
    [2]
    Liu J, Liu W, Mi L, et al. Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016[J]. J Hematol Oncol, 2019, 12(1): 136. doi: 10.1186/s13045-019-0807-5
    [3]
    Pulte D, Jansen L, Brenner H. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century[J]. Blood Cancer J, 2020, 10(5): 56. doi: 10.1038/s41408-020-0323-4
    [4]
    Fonseca R, Abouzaid S, Bonafede M, et al. Trends in overall survival and costs of multiple myeloma, 2000-2014[J]. Leukemia, 2017, 31(9): 1915-1921. doi: 10.1038/leu.2016.380
    [5]
    Sun T, Wang S, Sun H, et al. Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades[J]. Leuk Lymphoma, 2018, 59(1): 49-58. doi: 10.1080/10428194.2017.1335398
    [6]
    Costa LJ, Brill IK, Brown EE. Impact of marital status, insurance status, income, and race/ethnicity on the survival of younger patients diagnosed with multiple myeloma in the United States[J]. Cancer, 2016, 122(20): 3183-3190. doi: 10.1002/cncr.30183
    [7]
    Fiala MA, Finney JD, Liu J, et al. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma[J]. Leuk Lymphoma, 2015, 56(9): 2643-2649. doi: 10.3109/10428194.2015.1011156
    [8]
    Makhani SS, Shively D, Castro G, et al. Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study[J]. Leuk Res, 2021, 104: 106542. doi: 10.1016/j.leukres.2021.106542
    [9]
    Tang L, Pan Z, Zhang X. The effect of marital status on the survival of patients with multiple myeloma[J]. Hematology, 2022, 27(1): 187-197. doi: 10.1080/16078454.2022.2026027
    [10]
    Intzes S, Symeonidou M, Zagoridis K, et al. Socioeconomic Status Is an Independent Prognostic Factor for Overall Survival in Patients With Multiple Myeloma: Real-World Data From a Cohort of 223 Patients[J]. Clin Lymphoma Myeloma Leuk, 2020, 20(10): 704-711. doi: 10.1016/j.clml.2020.05.013
    [11]
    Castañeda-Avila MA, Jesdale BM, Beccia A, et al. Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicity[J]. Cancer Causes Control, 2021, 32(9): 1021-1028. doi: 10.1007/s10552-021-01454-w
    [12]
    Chamoun K, Firoozmand A, Caimi P, et al. Socioeconomic Factors and Survival of Multiple Myeloma Patients[J]. Cancers (Basel), 2021, 13(4): 590. doi: 10.3390/cancers13040590
    [13]
    Intzes S, Symeonidou M, Zagoridis K, et al. Socioeconomic Status is Globally a Prognostic Factor for Overall Survival of Multiple Myeloma Patients: Synthesis of Studies and Review of the Literature[J]. Mediterr J Hematol Infect Dis, 2021, 13(1): e2021006.
    [14]
    Collins GS, Reitsma JB, Altman DG, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement[J]. Ann Intern Med, 2015, 162(1): 55-63. doi: 10.7326/M14-0697
    [15]
    Harwood M, Dunn N, Moore J, et al. Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic status[J]. Leuk Lymphoma, 2020, 61(3): 721-727. doi: 10.1080/10428194.2019.1688322
    [16]
    Yu M, Tatalovich Z, Gibson JT, et al. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data[J]. Cancer Causes Control, 2014, 25(1): 81-92. doi: 10.1007/s10552-013-0310-1
    [17]
    Xu L, Wang X, Pan X, et al. Education level as a predictor of survival in patients with multiple myeloma[J]. BMC Cancer, 2020, 20(1): 737. doi: 10.1186/s12885-020-07178-5
    [18]
    Boen CE, Barrow DA, Bensen JT, et al. Social Relationships, Inflammation, and Cancer Survival[J]. Cancer Epidemiol Biomarkers Prev, 2018, 27(5): 541-549. doi: 10.1158/1055-9965.EPI-17-0836
    [19]
    Freeman A, Tyrovolas S, Koyanagi A, et al. The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe)[J]. BMC Public Health, 2016, 16(1): 1098. doi: 10.1186/s12889-016-3638-0
    [20]
    Bortolato B, Hyphantis TN, Valpione S, et al. Depression in cancer: The many biobehavioral pathways driving tumor progression[J]. Cancer Treat Rev, 2017, 52: 58-70. doi: 10.1016/j.ctrv.2016.11.004
    [21]
    Kruk J, Aboul-Enein BH, Bernstein J, et al. Psychological Stress and Cellular Aging in Cancer A Meta-Analysis[J]. Oxid Med Cell Longev, 2019, 2019: 1270397.
  • Related Articles

    [1]XIE Liang, LIU Chang, LI Jianhua, LI Jianhui, HAO Xin, HUA Haiyang. Risk Factor and Risk Prediction Modeling of Rectal Neuroendocrine Tumors[J]. Cancer Research on Prevention and Treatment, 2025, 52(7): 598-604. DOI: 10.3971/j.issn.1000-8578.2025.24.1089
    [2]YANG Rong, FANG Bin, ZHENG Lingling, CHEN Jinhua, ZHOU Wenjuan. Exploring Risk Factors for Primary Liver Cancer in Patients with Chronic Hepatitis C Based on Machine Learning Prediction Models[J]. Cancer Research on Prevention and Treatment, 2024, 51(12): 1015-1020. DOI: 10.3971/j.issn.1000-8578.2024.24.0590
    [3]LIU Chenghao, LU Ting, QIAN Fang, XU Yuanbing, HU Chaohua, SHEN Haoyuan. Establishment of Risk-Prediction Model for Axillary Lymph-Node Metastasis in Microinvasive Breast Cancer Based on SEER Database[J]. Cancer Research on Prevention and Treatment, 2024, 51(9): 750-755. DOI: 10.3971/j.issn.1000-8578.2024.24.0100
    [4]XIAO Yuxuan, LI Zhuoying, SHEN Qiuming, XIE Li, XIANG Yongbing. Progress of Risk Prediction Model for Liver Cancer in Population-Based Cohort Studies[J]. Cancer Research on Prevention and Treatment, 2024, 51(9): 711-717. DOI: 10.3971/j.issn.1000-8578.2024.24.0629
    [5]LIN Junsheng, YING Ziling, HUANG Zhengyuan, ZHU Xianjin, CAO Yingping, LU Pingxia. A Prediction Model for Colorectal Adenoma and Colorectal Cancer Based on Routine Test[J]. Cancer Research on Prevention and Treatment, 2024, 51(5): 353-360. DOI: 10.3971/j.issn.1000-8578.2024.23.1169
    [6]MA Junyan, WU Qiong, DONG Liang, LI Chunyang, WANG Zhiwu. Construction and Validation of A Predictive Model Including TCM Pathogenic Syndrome for Short-term Efficacy of PD-1 Inhibitors in Advanced Non-small Cell Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(10): 960-967. DOI: 10.3971/j.issn.1000-8578.2023.22.1513
    [7]DU Shuxiang, GUO Zhen, CHEN Zilai, WANG Shangxin, WU Gang. Risk Factors and Establishment of Prediction Model for Preoperative Lymph Node Staging Deficiency in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2023, 50(5): 498-504. DOI: 10.3971/j.issn.1000-8578.2023.22.1254
    [8]WU Qiong, MA Junyan, DONG Liang, LI Chunyang, WANG Zhiwu. Prediction Model of Treatment Effect of Anlotinib on Extensive-stage Small Cell Lung Cancer Based on Combination of Disease and Syndrome Information[J]. Cancer Research on Prevention and Treatment, 2023, 50(5): 483-489. DOI: 10.3971/j.issn.1000-8578.2023.22.1373
    [9]LIU Ying, XIE Bin, WANG Meng, LI Yiran, YAN Wenjin, XU Xingxiang, MIN Lingfeng. A Survival Prediction Model of Pulmonary Sarcomatoid Carcinoma Based on SEER Database[J]. Cancer Research on Prevention and Treatment, 2021, 48(9): 853-858. DOI: 10.3971/j.issn.1000-8578.2021.21.0259
    [10]SHI Xiangxiang, TANG Tao, CHEN Bin, PANG Haowen. Prediction Model of Parotid Mean Dose in Intensity Modulated Radiation Therapy on Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2017, 44(4): 253-256. DOI: 10.3971/j.issn.1000-8578.2017.04.003

Catalog

    Corresponding author: CHEN Bing, chenbing_nju@126.com

    1. On this Site
    2. On Google Scholar
    3. On PubMed

    Figures(6)  /  Tables(2)

    Article views (2535) PDF downloads (691) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return